330 likes | 912 Views
Enteral Nutrition In Critically Ill Patients. Role of Prokinetics. Focus on IV Erythromycin. Done by Dr Khaled Al Sewify MD, MRCP, EDIC. Artificial Nutritional Support. Enteral Nutrition. Preserves the intestinal mucosal integrity : Maintains mucosal immunity.
E N D
Enteral Nutrition In Critically Ill Patients Role of Prokinetics Focus on IV Erythromycin Done by Dr Khaled Al Sewify MD, MRCP, EDIC
Enteral Nutrition • Preserves the intestinal mucosal integrity : • Maintains mucosal immunity. • Prevents of increased mucosal permeability. • Decreases bacterial translocation. Marik, Zaloga CCM 2005
Theory of BT • SB and colon contain 1010 anaerobes and 107aerobesEnough Endotoxins to kill us 1000 X. Magnotti & Deitch 2005 JOABA
Advantages of gastric feeding • It is more physiological, is easier to begin and more convenient. • Spare both gastropancreatic reflexes and gastrin release. • Buffers gastric acid well.
What are The Problems Associated with Gastric Feeding in Critical Illiness ?
Gastric Ilieus Syndrome of Upper (GIT) Intolerance
Incidence of UGIT Intolerance to Gastric Feeding Mentec H (2001)– Crit Care Med 29 : 1955-1961
What Are The Sequelae Of Upper GIT Intolerance To Enteral Nutrition?
Hazards of UGIT Intolerance Incidence of Nosocomial Pneumonia Feeding intolerance
Hazards of UGIT Intolerance Mortality Rate Feeding intolerance
Aspiration Syndrome. • So probably the gastric feeding may not always be as safe as it is sometimes considered. • The net result is Aspiration Syndrome. Heyland DK 199-AM J RespirCrit Care Med 159:1249-1256. Real Threat
Aspiration Syndrome 1. 70% with altered LOC. 2. > 70% of trauma patients at injury. 3. > 40% of patients with EN. Bowman, et al CCNQ 2005 Real Threat Real Threat
They Have To Balance TPN Small Bowel Feeding Prokinetics
Prokineticsvs Small Bowel Feeding One study (80 patients) compared the use of prokinetic drugs (erythromycin) in patients receiving gastric feeding with small bowel feeding (without erythromycin) and it found no differencesbetween the 2 groups in the adequacy of EN, mortality & duration of ICU stay. Gastric feeding with erythromycin is equivalent to transpyloric feeding in critically ill.2001. Crit Care Med 29:1916-1919.
Prokinetic Therapy For Feeding Intolerance • Metoclopramide : • Site of action : dopaminergic receptors. Role Controversial *Jooste C & others : Metoclopramide improves gastric motility in critically ill patients. Intensive Care Med 1999; 25:464–468 *MacLaren R & othes : : A randomized, placebo-controlled, crossover study. Crit Car Med 2000; 28:438–444
Erythromycin • Site of action : motilin receptors. • Dose : 3-7 mg/kg. • Optimum dose : 200mg IV bid to 250mg q 6 h. • Half life : 1.5h But Antrum Motility > 5h & Feeding Tolerance up to 24h.
Erythromycin VS Metoclopramide Nguyen 2007 trial : • RCT, Multicenter,Double blind. • 107 patients enrolled. • Metoclopramide10mg/6hvs Erythromycin 200mg/12hrs. • 1ry endpoint : tolerance to gastric feed and tachyphylaxis. Nguyen NQ & others : Erythromycin is more effective than metoclopramide for treatment of feed intolerance in critical illness. Crit Care Med 2007; 35:483–489
Erythromycin versus Metoclopramide After 24 hrs of rescue combination therapy 92% achieved & remained tolerant for 5 days. P < 0.0001 Erythromycin is much more effective than Metoclopramide Metoclopramide became intolerant early
Prokinetic therapy for feed intolerance in critical illnes : one drug or two ? Australian double blinded RCT 75 Patients enrolled. Erythromycin (200mg IV bd) alone vs Erythromycin Metocclopramide(10mg q 6h). 1ry endpoint : successful feeding over 7 days 2ry endpoint : daily caloric intake, vomiting, post pyloric feeding requirement, LOS & mortality.
Gastric residual volume was significantly lower after 24 hrs 136 ± 23 mL 293 ±45 mL P =.04
Tolerance &Failure of therapy Erythromycin alone Erythromycin Metoclopramide
Combination Therapy vs Erythromycin Alone Over 7 Days Nguyen NQ - Crit Care Med. 2007 Nov;35(11):2561-7.
Oral vs IV Erythromycin • Most of the well powered trials used erythromycin IV. • No head to head trials.
Side Effects of Prokinetics • Metoclopramide : extrapyramidal syndrome. • Erythromycin : bacterial resistance & cardiac toxicity. • Both : rapid tachyphylaxis.
What is new ? • Motilin derivatives : • Long term efficacy is unknown. • Very rapid tachyphylaxis. • Cholecystokinin antagonist : Loxiglumide • Very recent. • Accelerate gastric emptying in healthy humans. • No trials in critically ill patients. * Castllo E, et al .Am J Physiol 2004;287:G363-G369 * CremoniniF,etal.Am J Gastroenterol 2005;100:625-663
SUMMARY • Enteral Nutrition is very Crucial for critically ill patients. • UGIT Intolerance is very common with critical illness. • Prokinetics are the easiest option to overcome this problem. • Erythromycin in IV form is more effective than Metoclopramide in achieving tolerance to gastric feeding but both therapy are associated with tachyphylaxis.
SUMMARY • Combination of both Metoclopramide and Erythromycin is much more effective than either of them alone with much less incidence of tachyphylaxis.
THANK YOU